Lianhua? Yiling? Yiling Pharmaceutical, the exclusive manufacturer of Lianhua Qingwen in the replacement of old and new packaging, issued an "About Lianhua" in response to the trademark issue of Lianhua Qingwen as early as April this year. "Instructions on the Packaging Forms of Qingwen Capsules/Granules" points out that Lianhua Qingwen Capsules/Granules (hereinafter referred to as "Lianhua Qingwen") products on the market within the validity period have two outer packaging forms, showing "Yiling" and The two trademarks "Lianhua" are because the company is optimizing product classification management, uniformly using the "Lianhua" trademark for respiratory system-related products, and replacing the old packaging of the original "Yiling" trademark with the new packaging of the "Lianhua" trademark . The appearance of the pill box has also changed slightly, as shown in the picture below. Due to packaging changes, two outer packaging products temporarily coexist on the market. Lianhua Qingwen has changed its old and new packaging. The medicines in both packages are genuine and consumers can use them with confidence.

It is "Lianhua Qingwen" and not "Lianhua Qingwen". If you are careful, you may have discovered long ago that it is "Lianhua Qingwen" and not "Lianhua Qingwen". "Lotus" is an ornamental plant that everyone recognizes, so what is "Lianhua"? Looking at the ingredient list of Lianhua Qingwen, there is no such thing as "Lianhua". The top two drugs in the ingredient list are: Forsythia suspensa and honeysuckle. In fact, the name of Lianhua Qingwen is taken from these two traditional Chinese medicines. "Lian" refers to forsythia and "hua" refers to honeysuckle. Lianhua Qingwen is based on the Maxing Shigan Decoction in Zhang Zhongjing's Treatise on Febrile and Miscellaneous Diseases in the Eastern Han Dynasty and Yinqiao Powder in Wu Jutong's Treatise on Febrile Diseases in the Qing Dynasty, and draws on Wu Youke's experience in using rhubarb to treat epidemic diseases in the Ming Dynasty. It is combined with Patchouli to aromatize dampness and protect the spleen and stomach, and Rhodiola rosea to regulate immunity and strengthen righteousness. In other words, it combines the medicinal experience of famous doctors from the Han, Ming and Qing dynasties in treating colds, flu and other exogenous fevers, combined with modern pharmacology. Research, refine and develop new drugs, which have become famous drugs for antiviral treatment. In April 2020, the State Food and Drug Administration approved Lianhua Qingwen to add a new indication of "mild and common type of novel coronavirus pneumonia" on the basis of the original approved indications. Previously, Lianhua Qingwen was approved for the treatment of influenza, which is characterized by heat poison attacking the lungs, with symptoms such as fever, aversion to cold, and muscle aches.

How to choose between Lianhua Qingwen capsules and granules? The common ones on the market are Lianhua Qingwen capsules and Lianhua Qingwen granules. These two dosage forms have the same formula, efficacy and indications, and both are Oral medication, that is, all dosage forms are administered through the gastrointestinal tract. Capsules are solid preparations made by filling the active ingredients of drugs into capsules. This dosage form is more convenient to control the dispersion, decomposition, dissolution and absorption time of the capsule in the gastrointestinal tract to achieve delayed and targeted release of the drug. purpose. Granules have the characteristics of fast absorption and rapid effect. In addition, granules are suitable for some people with poor swallowing function or poor medication compliance, such as children, the elderly and people with swallowing dysfunction. However, since the granules need to be mixed with warm boiled water before use, it is more convenient to choose Lianhua Qingwen capsules when you need to go on a business trip or travel.

Who else is there in the "Lianhua" series? According to the reply from the Yiling Pharmaceutical Board Secretary on the investor relations platform, "Lianhua" is a sub-brand established under the company's parent brand based on the company's brand strategy requirements. Brand, in the future the outer packaging trademark of Lianhua series products will be uniformly replaced with the Lianhua logo. Currently, in the field of respiratory disease treatment, Lianhua Qingwen capsules/granules for treating colds, flu, and COVID-19, and Lianhua Qingke tablets for treating cough and sputum have been developed and put on the market. In the field of general health, the "Lianhua" brand adheres to the concept of "preventing disease before it becomes ill" and continues Lianhua Qingwen's advantages in treating respiratory diseases. It has developed Lianhua Qingfei tea, Lianhua Qingwen explosive bead masks, and Lianhua Qingyan Antibacterial spray, Lianhua air disinfection gel and other Lianhua series respiratory health products protect respiratory health. (Picture and text by Ye Xuan)